跳至主要内容
临床试验/ACTRN12619000194167
ACTRN12619000194167已完成未知

The effect of a wearable activity tracker on the length of hospital stay for gastrointestinal cancer patients: A randomised controlled trial (the Fit-4-Home Trial)

Sydney Local Health District0 个研究点目标入组 96 人开始时间: 2019年2月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients must be adults aged 18-85 years and scheduled to undergo elective surgery for liver, stomach and pancreatic cancer with one of the participating surgeons at the Royal Prince Alfred Hospital, or the Chris O'Brien Lifehouse, Sydney.

排除标准

  • Patients will be excluded from participating in this trial if they present:
  • Cognitive impairment such that they are unable to provide informed consent.
  • Unable to place a Fitbit on patient’s wrist (including size and/or allergy).
  • Neurological deficit which requires assistance in mobilisation (e.g. stroke, post limb amputation).
  • Insufficient English language to complete outcome measures

研究者

相似试验